{"entity":{"type":"insider","cik":"0001253256","url":"/insider/0001253256","json_url":"/insider/0001253256.json","name":"SPICER MICHAEL E B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2005-07-01","last":"2007-08-21","span_basis":"filed_date"},"name_variants":[{"name":"SPICER MICHAEL E B","source":"filing","n_filings":4,"first_seen":"2005-07-01","last_seen":"2007-08-21"}],"transactions":[{"id":7124277,"accession":"0000950117-07-001063","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950117-07-001063","line_url":"/filing/0000950117-07-001063#line-3","is_derivative":false,"issuer_cik":"0001043873","issuer_name":"NOVADEL PHARMA INC","issuer_ticker":"NVD","issuer_name_source":null,"issuer_url":"/issuer/0001043873","owner_cik":"0001253256","owner_name":"SPICER MICHAEL E B","owner_url":"/insider/0001253256","role":"Officer (CFO and Corporate Secretary)","officer_title":"CFO and Corporate Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22400.0,"shares_display":"22,400","price_per_share":0.66,"price_display":"0.66","price_state":"stated","total_value":14784.0,"total_display":"14,784.00","shares_owned_after":39000.0,"shares_owned_after_display":"39,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-20","filed_date":"2007-08-21","scope":"insider"},{"id":7124276,"accession":"0000950117-07-001063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950117-07-001063","line_url":"/filing/0000950117-07-001063#line-2","is_derivative":false,"issuer_cik":"0001043873","issuer_name":"NOVADEL PHARMA INC","issuer_ticker":"NVD","issuer_name_source":null,"issuer_url":"/issuer/0001043873","owner_cik":"0001253256","owner_name":"SPICER MICHAEL E B","owner_url":"/insider/0001253256","role":"Officer (CFO and Corporate Secretary)","officer_title":"CFO and Corporate Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4100.0,"shares_display":"4,100","price_per_share":0.63,"price_display":"0.63","price_state":"stated","total_value":2583.0,"total_display":"2,583.00","shares_owned_after":13100.0,"shares_owned_after_display":"13,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-20","filed_date":"2007-08-21","scope":"insider"},{"id":7124275,"accession":"0000950117-07-001063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-07-001063","line_url":"/filing/0000950117-07-001063#line-1","is_derivative":false,"issuer_cik":"0001043873","issuer_name":"NOVADEL PHARMA INC","issuer_ticker":"NVD","issuer_name_source":null,"issuer_url":"/issuer/0001043873","owner_cik":"0001253256","owner_name":"SPICER MICHAEL E B","owner_url":"/insider/0001253256","role":"Officer (CFO and Corporate Secretary)","officer_title":"CFO and Corporate Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":2240.0,"total_display":"2,240.00","shares_owned_after":16600.0,"shares_owned_after_display":"16,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-20","filed_date":"2007-08-21","scope":"insider"},{"id":5350316,"accession":"0000950117-06-002771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-06-002771","line_url":"/filing/0000950117-06-002771#line-1","is_derivative":false,"issuer_cik":"0001043873","issuer_name":"NOVADEL PHARMA INC","issuer_ticker":"NVD","issuer_name_source":null,"issuer_url":"/issuer/0001043873","owner_cik":"0001253256","owner_name":"SPICER MICHAEL E B","owner_url":"/insider/0001253256","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":2070.0,"total_display":"2,070.00","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-06-23","filed_date":"2006-06-27","scope":"insider"},{"id":4888330,"accession":"0001043873-06-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001043873-06-000001","line_url":"/filing/0001043873-06-000001#line-1","is_derivative":false,"issuer_cik":"0001043873","issuer_name":"NOVADEL PHARMA INC","issuer_ticker":"NVD","issuer_name_source":null,"issuer_url":"/issuer/0001043873","owner_cik":"0001253256","owner_name":"SPICER MICHAEL E B","owner_url":"/insider/0001253256","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.18,"price_display":"1.18","price_state":"stated","total_value":5900.0,"total_display":"5,900.00","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-29","filed_date":"2006-01-03","scope":"insider"},{"id":1398982,"accession":"0001253256-05-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253256-05-000002","line_url":"/filing/0001253256-05-000002#line-1","is_derivative":false,"issuer_cik":"0001043873","issuer_name":"NOVADEL PHARMA INC","issuer_ticker":"NVD","issuer_name_source":null,"issuer_url":"/issuer/0001043873","owner_cik":"0001253256","owner_name":"SPICER MICHAEL E B","owner_url":"/insider/0001253256","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-30","filed_date":"2005-07-01","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001043873","name":"NOVADEL PHARMA INC","url":"/issuer/0001043873","role":"Officer (CFO and Corporate Secretary)","n_filings":4,"first_seen":"2005-07-01","last_seen":"2007-08-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001253256","retrieved_at":"2026-08-21T16:00:31+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}